United States Federal Circuit
Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 17-1487
Reversing the US Patent and Trademark Office's Patent Trial and Appeal Board decision regarding the As Sawaya Declarations, vacating the determination that test data did not satisfy statutory requirements and that the Asserted Claims would not have been obvious and remanding for further consideration in a case relating to pupil dilation drugs.
Appellate Information
- Published 2018/05/11
Judges
- WALLACH
Court
- United States Federal Circuit